SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037953
Filing Date
2023-08-03
Accepted
2023-08-03 16:07:45
Documents
65
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20230630.htm   iXBRL 10-Q 3343596
2 EX-10.3 igms-ex10_3.htm EX-10.3 173253
3 EX-31.1 igms-ex31_1.htm EX-31.1 19093
4 EX-31.2 igms-ex31_2.htm EX-31.2 17433
5 EX-32.1 igms-ex32_1.htm EX-32.1 11353
6 EX-32.2 igms-ex32_2.htm EX-32.2 11333
  Complete submission text file 0000950170-23-037953.txt   10320157

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20230630.xsd EX-101.SCH 58320
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igms-20230630_cal.xml EX-101.CAL 44358
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20230630_lab.xml EX-101.LAB 473469
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20230630_pre.xml EX-101.PRE 356890
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igms-20230630_def.xml EX-101.DEF 229928
59 EXTRACTED XBRL INSTANCE DOCUMENT igms-20230630_htm.xml XML 1789938
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 231139936
SIC: 2834 Pharmaceutical Preparations